Hikari Power LTD Dynavax Technologies Corp Transaction History

Hikari Power LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 23, 2020	SELL	$2.27 - $6.2 $239,650 - $654,552	-105,573 Closed	0 $0
Q4 2018 Jan 29, 2019	SELL	$8.14 - $13.28 $408,481 - $666,416	-50,182 Reduced 32.22%	105,573 $966,000
Q3 2018 Oct 31, 2018	BUY	$11.85 - $16.0 $296,250 - $400,000	25,000 Added 19.12%	155,755 $1.93 Million
Q2 2018 Aug 02, 2018	BUY	$15.15 - $20.75 $333,300 - $456,500	22,000 Added 20.23%	130,755 $1.99 Million
Q3 2017 Nov 08, 2017	BUY	$15.2 - $21.5 $380,000 - $537,500	25,000 Added 29.85%	108,755 $2.34 Million
Q2 2017 Aug 09, 2017	BUY	N/A	83,755	83,755 $808,000

288

131M

507K

374K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.74B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Hikari Power LTD, based on Form 13F filings with the SEC.

Stay updated on Hikari Power LTD with notifications on news.